English 
Spanish 
French 
German 
Italian 
Portuguese How to Choose a Custom Battery Pack Manufacturer for Medical Devices
Table of Contents
- How to Choose a Custom Battery Pack Manufacturer for Medical Devices
- What Should Medical OEMs Expect from a Battery Pack Manufacturer?
- Which UK Rules and Battery Standards Apply?
- How Should a Battery Pack Manufacturer Define the Specification?
- Battery Chemistry and Cell Selection for Medical Devices
- How Do BMS and Charging Design Affect Patient Safety?
- What Testing Should a Battery Manufacturer Provide?
- Quality Systems, Traceability and Change Control
- Can the Battery Pack Manufacturer Scale and Support the Programme?
- MANLY Battery Medical Battery Customisation Capabilities
- Final Battery Pack Manufacturer Selection Framework
- Learn More About Battery
Choosing a Battery Pack Manufacturer for a medical device requires more than comparing voltage, capacity and unit price. The supplier must translate the device’s clinical use, electrical load, operating environment and regulatory pathway into a controlled battery design. A reliable partner also needs to support prototyping, verification, traceability, change control and repeatable production throughout the device lifecycle.
A medical OEM should therefore assess the complete development process behind each Custom Battery Pack. Cell quality matters, but safe operation also depends on the BMS, charger, enclosure, connectors, firmware, production controls and device-level risk management. The strongest sourcing decision links engineering evidence with the documentation required for the intended UK and international markets.
What Should Medical OEMs Expect from a Battery Pack Manufacturer?
A qualified Battery Pack Manufacturer should act as an engineering and manufacturing partner, not simply assemble cells to a drawing. Medical OEMs should expect structured requirements capture, documented design decisions, prototype support, controlled production and clear responsibility for battery-related verification. The battery manufacturer’s evidence should show that it can convert a clinical use case into a repeatable, testable battery system.
Proven Medical Device Battery Experience
Relevant experience helps a battery manufacturer recognise risks that may not appear in a basic electrical specification. Portable monitors, infusion systems, respiratory equipment, diagnostic instruments and powered medical carts can impose very different requirements for standby time, pulse current, charging access, cleaning exposure and alarm behaviour.
Ask the supplier to explain how it has handled comparable duty cycles and environments. Useful evidence may include anonymised project summaries, design inputs, prototype records, validation plans or production-control examples. The goal is not to obtain confidential customer data from the battery manufacturer. It is to confirm that the Battery Pack Manufacturer understands medical-device development rather than only general industrial assembly.
Clear Engineering and Regulatory Ownership
The medical device manufacturer retains responsibility for the finished device and its market route, while the Battery Pack Manufacturer controls the supplied battery design. The Battery Pack Manufacturer should define which deliverables it owns, such as pack drawings, BMS parameters, component specifications, production tests, traceability records and transport documents. The OEM should separately define device-level risk management, conformity assessment, clinical evidence and final technical documentation.
A clear responsibility matrix prevents gaps between the Custom Battery Pack, charger and host device. It should name the owner for electrical interfaces, communication protocols, alarm thresholds, software changes, test samples and approval of substitute components. This structure also makes design reviews faster because each party knows which evidence it must produce.
Evidence of Similar Custom Battery Programmes
A credible Battery Pack Manufacturer should demonstrate a controlled path from initial specification to stable production. Look for evidence of requirements reviews, engineering samples, design verification builds, pilot runs and production release. Comparable programme experience is more useful than a catalogue showing many unrelated battery products.
The evidence should also show how the Battery Pack Manufacturer handled design changes. A medical project may need a revised connector, enclosure, firmware threshold or cell source during development. The battery manufacturer should document the reason, risk assessment, verification impact and customer approval before introducing the change.
Which UK Rules and Battery Standards Apply?
UK market access depends on where the finished medical device will be sold, how it is classified and which conformity route the manufacturer uses. A Battery Pack Manufacturer can provide battery-related evidence, but the OEM must connect that evidence to the finished device’s regulatory strategy. Great Britain and Northern Ireland follow different frameworks, so one generic “UK compliance” statement is not sufficiently precise.
Great Britain Market Access Requirements
Great Britain covers England, Wales and Scotland. Medical devices placed on this market are regulated under the UK Medical Devices Regulations 2002, as amended. Devices must be registered with the MHRA before being placed on the market, and a manufacturer established outside the UK must appoint a UK Responsible Person.
The UKCA route is available for Great Britain. CE-marked devices also remain accepted under transitional arrangements, with current deadlines extending to 30 June 2028 or 30 June 2030 depending on the device and the EU legislation used. A battery manufacturer should not present a cell or pack certificate as proof that the complete medical device has met these requirements.
Northern Ireland Rules for Medical Devices
Northern Ireland follows the EU Medical Device Regulation and EU In Vitro Diagnostic Medical Device Regulation under the Windsor Framework. CE marking applies, while the UKNI indication is required when a UK notified body performs a mandatory third-party conformity assessment. Great Britain-based manufacturers also need an authorised representative in the EU or Northern Ireland.
Since 28 May 2026, non-custom-made devices intended for the EU or Northern Ireland markets must be registered in EUDAMED before placement on those markets. Custom-made devices continue to follow the separate MHRA registration provisions stated in the current guidance. These obligations belong to the device manufacturer, although the Battery Pack Manufacturer must provide controlled battery documentation that supports the technical file.
Battery and Device Standards to Confirm
The Battery Pack Manufacturer must match standards to the battery architecture and the intended device. ISO 13485 defines a quality management framework for organisations involved in medical-device design and manufacture, while ISO 14971 provides the process for identifying hazards, evaluating risk, implementing controls and monitoring their effectiveness across the device lifecycle.
IEC 62133-2 addresses the safe operation of portable sealed secondary lithium cells and batteries under intended use and reasonably foreseeable misuse. IEC 60601-1 addresses basic safety and essential performance for medical electrical equipment, with collateral or particular standards applying to specific environments and device types. UN 38.3 addresses lithium-cell and battery transport classification rather than complete medical-device conformity.
| Requirement | Primary purpose | Typical evidence to review |
|---|---|---|
| UK MDR 2002 and MHRA registration | Great Britain market access | Device registration, responsible-person and conformity records |
| EU MDR or EU IVDR | Northern Ireland market access | Classification, technical documentation and CE route |
| ISO 13485 | Medical-device quality management | Certificate scope, audited site and applicable processes |
| ISO 14971 | Medical-device risk management | Hazard analysis, risk controls and verification evidence |
| IEC 62133-2 | Portable rechargeable lithium battery safety | Test report linked to the actual cell and pack configuration |
| IEC 60601 series | Medical electrical equipment safety and performance | Device-level test plan and applicable collateral or particular standards |
| UN 38.3 | Lithium battery transport testing | Test report and test summary for the shipped configuration |
How Should a Battery Pack Manufacturer Define the Specification?
A Battery Pack Manufacturer should begin with the medical device’s real duty profile, not a preferred cell or a standard catalogue pack. The specification must convert operating time, peak load, charging method, environmental exposure and lifecycle expectations into measurable limits. This process gives the OEM a defensible basis for cell selection, BMS settings, mechanical design and verification testing.
Translate Device Duty into Battery Requirements
The battery manufacturer should start with a load profile that separates continuous demand, transient peaks, standby consumption and start-up current. Record the device modes that matter clinically, including normal operation, alarms, communications, displays, pumps, heaters and emergency functions. The battery manufacturer can then calculate the required voltage window, usable capacity, discharge current and thermal margin.
The specification should also define the charging scenario. A device charged overnight in a controlled ward has different needs from a mobile cart that receives short opportunity charges throughout the day. A removable Custom Battery Pack may require contact protection, insertion detection or a separate docking interface, while an internal pack may rely on host-controlled charging.
Define Runtime at End-of-Life Conditions
Runtime targets should apply at the defined end-of-life condition, not only when the battery is new. Capacity changes with ageing, temperature, discharge rate and storage history. The OEM should specify the minimum operating time, warning period and shutdown behaviour that remain acceptable after the planned service interval.
A sound Battery Pack Manufacturer will build margin into the energy calculation and verify the pack against representative loads. The Custom Battery Pack test plan should include the intended operating temperature range and the lowest acceptable state of health. This approach gives the medical OEM a measurable replacement criterion instead of relying on an optimistic nominal-capacity figure.
Set Mechanical and Environmental Design Limits
The Custom Battery Pack mechanical specification should control length, width, height, mass, connector position, cable routing, mounting points and service access. It should also identify expected shock, vibration, cleaning exposure, liquid contact, humidity, storage temperature and operating temperature. These requirements shape the enclosure, insulation, strain relief and cell-retention method.
Materials and seals must suit the device’s intended environment. A Custom Battery Pack used in portable hospital equipment may face frequent handling and disinfectant cleaning, while home healthcare equipment may face transport, uncontrolled storage and lay-user handling. IEC 60601-1-11 provides additional requirements for medical electrical equipment used in the home healthcare environment, so the device team should consider it where applicable.
Battery Chemistry and Cell Selection for Medical Devices
No single chemistry suits every medical device programme. The correct choice balances energy density, power capability, thermal behaviour, cycle life, service interval, mass, available space and charging strategy. A responsible Battery Pack Manufacturer should compare these factors against the intended use rather than describe one lithium chemistry as universally superior.
Primary or Rechargeable Architecture
Primary batteries may suit devices with very low average power, long shelf periods or infrequent use. Rechargeable batteries usually fit equipment that operates regularly, requires higher energy or needs predictable servicing. The decision should account for replacement access, user training, waste handling, storage controls and the consequences of an unavailable charger.
A rechargeable Custom Battery Pack also introduces charger integration, ageing management and state-of-charge reporting. The battery manufacturer should help define the cell voltage window and protection thresholds, while the medical OEM confirms that the complete device maintains its essential performance during charging, low-battery operation and power-source transitions.
Compare Lithium-Ion Chemistry Trade-offs
A Battery Pack Manufacturer should explain that lithium-ion families offer different engineering balances. Nickel-based lithium-ion chemistries can provide high energy density for compact portable equipment. Lithium iron phosphate can support applications that prioritise thermal stability, cycle life and sustained power over minimum size and mass. Lithium-polymer describes a construction approach commonly associated with pouch cells and flexible form factors, rather than one universal performance level.
Each Custom Battery Pack selection must rely on verified cell data for the exact model. A Battery Pack Manufacturer should evaluate discharge curves, maximum current, charging limits, temperature performance, dimensional tolerance and supply status. Broad chemistry labels cannot replace model-specific evidence or testing in the final Custom Battery Pack.
Select Cell Format and Provenance
Cylindrical, prismatic and pouch cells create different options for packaging, thermal paths and mechanical restraint. Pouch cells can fit thin or irregular spaces, while cylindrical cells may offer established automated assembly options. Prismatic cells can suit larger-capacity equipment where enclosure volume and structural support allow their use.
The battery manufacturer should disclose the approved cell manufacturer, model, production site and revision status. It should also maintain lot traceability and incoming inspection records. This provenance matters because a cell substitution can change electrical behaviour, dimensions, safety evidence and the validity of previous verification work.
How Do BMS and Charging Design Affect Patient Safety?
The BMS and charging architecture control how the Custom Battery Pack responds to abnormal voltage, current and temperature conditions. They also influence low-battery warnings, available runtime and fault reporting. A medical OEM should treat the BMS as part of the device’s risk-control system and verify its behaviour together with the charger, wiring, connectors and host software.
Build Protection Around Foreseeable Faults
The Battery Pack Manufacturer should configure core protective functions that commonly include overcharge, over-discharge, overcurrent, short-circuit and temperature limits. The exact thresholds must match the cell model, pack architecture and device load. The Battery Pack Manufacturer should document how hardware protection, firmware logic, fuses and host controls interact rather than relying on one generic protection board.
ISO 14971 requires a structured process for identifying hazards, estimating and evaluating risks, applying controls and monitoring their effectiveness. The OEM can use that process to assess foreseeable faults such as a failed temperature sensor, blocked ventilation, damaged connector or charger mismatch. The resulting controls should feed directly into the battery manufacturer’s design inputs and verification plan.
Validate State-of-Charge Accuracy
State-of-charge information affects clinical workflow because users need sufficient warning before a device loses power. The algorithm may use voltage, current integration, temperature and learned capacity. Accuracy can change as the cells age or operate outside the calibration conditions.
The Battery Pack Manufacturer should validate the fuel-gauge behaviour across representative loads, temperatures and ageing states. The medical OEM should then confirm how the device displays remaining energy, issues warnings and enters a safe state. A percentage display alone is not enough unless the system links it to a defined runtime and alarm strategy.
Integrate Charger and Device Communications Safely
The charger, battery and host device must use compatible voltage, current and temperature limits. Communication may use SMBus, I²C, UART, CAN or another defined interface, depending on the equipment. The Custom Battery Pack interface specification should cover normal data, invalid messages, timeouts, wake-up behaviour and safe responses to communication loss.
A competent battery manufacturer will document pin assignments, message definitions, firmware versions and charging permissions. The OEM should verify the complete system during mains operation, battery operation, charging and source transitions. IEC 60601-1 focuses on the basic safety and essential performance of medical electrical equipment, so pack-level tests do not replace this device-level work.
What Testing Should a Battery Manufacturer Provide?
A battery manufacturer should provide test evidence tied to the exact cells, BMS, enclosure and production configuration supplied to the project. The Battery Pack Manufacturer’s reports should identify the tested sample and applicable standard, while change control should preserve the link between the report and mass production. Medical OEMs must still perform device-level verification because pack certification cannot demonstrate every interaction within the finished equipment.
Cell and Pack Safety Test Evidence
For portable rechargeable lithium systems, IEC 62133-2 provides requirements and tests covering safe operation under intended use and reasonably foreseeable misuse. The OEM should confirm that the Custom Battery Pack report applies to the correct cell model, series-parallel arrangement, protection circuit and pack construction.
The Battery Pack Manufacturer should also provide routine production-test records appropriate to the design. These may cover voltage, capacity, internal resistance, protection operation, communication, insulation or functional checks. Test limits, instruments and acceptance criteria should remain under document control so the evidence stays consistent across batches.
Device-Level Verification under Fault Conditions
The medical OEM must verify that the finished device and Custom Battery Pack maintain basic safety and essential performance under applicable normal and fault conditions. Testing should include the battery states and failures identified through risk management, such as low charge, sudden disconnection, sensor faults, communication loss, charger failure or reduced capacity.
The battery manufacturer should support this work with representative samples, interface data and fault-injection options where practical. Particular device standards or collateral standards may add requirements beyond IEC 60601-1. For example, IEC 60601-1-2 addresses electromagnetic disturbances, while IEC 60601-1-12 covers equipment intended for emergency medical services environments.
UN 38.3 Transport Documentation
Lithium cells and batteries offered for transport must meet the applicable UN 38.3 test requirements. The UN Manual of Tests and Criteria contains the relevant procedures, and the current documentation should match the cell or battery configuration being shipped.
Request the test report and test summary from the Battery Pack Manufacturer, then compare the product name, model, mass, watt-hours and configuration with the commercial pack. UN 38.3 demonstrates transport-test compliance. It does not replace IEC battery safety evaluation, medical electrical equipment testing or medical-device market authorisation.
Quality Systems, Traceability and Change Control
Consistent medical-device supply depends on controlled processes as much as initial design performance. A Battery Pack Manufacturer should maintain approved specifications, trained production methods, inspection records, non-conformance controls and traceability from critical components to finished packs. The OEM should assess whether the supplier’s quality system covers the actual site and activities used for the programme.
Confirm the ISO 13485 Certification Scope
ISO 13485 is an internationally recognised quality management standard for organisations involved in medical-device design and manufacture. A certificate can strengthen supplier qualification when its scope, site and covered activities align with the work being purchased. The OEM should review the certificate details rather than relying only on an ISO 13485 logo.
A battery manufacturer without responsibility for the finished medical device does not become the legal device manufacturer merely by supporting an ISO 13485-controlled project. Contracts and quality agreements should define the supplied product, documentation, audit rights, notification duties and approval process for changes.
Maintain Component and Batch Traceability
The Battery Pack Manufacturer should connect each finished Custom Battery Pack to its cell lot, BMS hardware, firmware version, enclosure, connector, key process records and final test result. Serialisation or lot coding enables targeted investigation if a field issue appears. It also helps the OEM determine which devices contain a specific component revision.
The Battery Pack Manufacturer should retain records for an agreed period that supports the device lifecycle and regulatory strategy. The quality agreement should also define access to certificates, material declarations, inspection data and failure-analysis records. Clear ownership avoids delays during audits, complaints or corrective actions.
Control Engineering Changes and CAPA
A Battery Pack Manufacturer should not change a cell, protection component, firmware parameter, connector, material or production process without following the agreed notification and approval route. Even a seemingly minor substitution can affect safety testing, EMC behaviour, runtime, fit or the device risk file.
The battery manufacturer should use formal non-conformance, root-cause and corrective-and-preventive-action processes. The OEM should define which changes require prior approval, new samples or repeat verification. This Custom Battery Pack discipline supports the medical device’s ongoing safety and performance after market release.
Can the Battery Pack Manufacturer Scale and Support the Programme?
A Battery Pack Manufacturer must show that the design can move from a few engineering samples to controlled serial production without losing configuration integrity. The evaluation should cover prototype discipline, process validation, capacity planning, cell availability and lifecycle support. A low sample price has little value if the supplier cannot reproduce the validated Custom Battery Pack at the required volume.
Prototype, Verification and Pilot Build Stages
The Battery Pack Manufacturer should give every development build a defined purpose. Early prototypes may test fit, runtime or communication. Verification units should use production-intent cells, BMS hardware, firmware, connectors and enclosure materials wherever possible. Pilot builds then confirm that the manufacturing process can repeatedly meet the released specification.
The battery manufacturer should label each build by revision and retain its bill of materials, drawings, firmware and test results. This avoids confusion between demonstration samples and validation units. It also gives the OEM a reliable baseline for design reviews and regulatory evidence.
Validate Production Processes before Volume Release
Critical operations may include cell sorting, welding, soldering, insulation placement, adhesive application, enclosure closing, firmware programming and final functional testing. The Battery Pack Manufacturer should identify which processes need controlled parameters, operator qualification, maintenance or validation because output quality cannot be fully confirmed by final inspection alone.
A battery manufacturer can use a pilot run to expose assembly variation, test bottlenecks and packaging issues before volume release. The OEM and battery manufacturer should review yield data, non-conformances and corrective actions. Approved limits should then transfer into the production control plan for the released Custom Battery Pack.
Review Commercial and Supply Resilience
The battery manufacturer’s commercial review should separate one-time engineering charges, tooling, certification support, samples and production pricing. It should also state the minimum order quantity, forecast process, lead time, warranty method and responsibility for failure analysis. Transparent terms help the OEM compare suppliers on lifecycle cost rather than unit price alone.
Supply resilience requires approved cell sources, component-lifecycle monitoring and notice of obsolescence. The battery manufacturer should explain how it manages constrained components and whether an alternative would trigger redesign or revalidation. A long-term medical programme benefits from documented continuity planning and stable technical support.
MANLY Battery Medical Battery Customisation Capabilities
MANLY Battery provides a dedicated medical equipment battery offering and supports project-specific configuration rather than limiting OEMs to one fixed pack. Its published customisation options cover voltage, capacity and physical dimensions, while product-level OEM information also identifies configurable BMS current, connectors, casing and wiring. These capabilities allow a medical OEM to align the Custom Battery Pack with the device’s electrical and mechanical architecture.
Verified Medical Battery Customisation
MANLY Battery’s medical equipment battery page confirms that customers can tailor the battery voltage to specific device needs. The company’s wider custom-battery offering also covers capacity, size and design. This flexibility supports medical equipment projects that cannot use a standard catalogue enclosure or electrical configuration.
For an OEM, this means the Battery Pack Manufacturer can begin from the device requirements and develop a matching pack architecture. The project team can define the operating voltage, usable energy, current demand, available installation space and service method before finalising the cell arrangement and enclosure.
Configurable Voltage, Capacity and BMS
MANLY Battery publishes OEM and ODM options for battery voltage, capacity and dimensions, along with BMS charging and discharging current. It also lists connector, case and wire customisation. These parameters cover the interfaces that often determine whether a Custom Battery Pack integrates cleanly into a medical device.
The medical OEM can use these options to specify a pack around the real load profile and mechanical envelope. BMS limits, cable size, connector selection and enclosure layout can then follow the agreed current, charging and environmental requirements rather than forcing the device to accommodate an unsuitable standard pack.
Match Published Packs to Device Loads
MANLY Battery’s published medical equipment battery range provides a starting point for discussing voltage and capacity classes. The final selection should still follow the medical device’s duty cycle, runtime target, space, mass and current requirements. This engineering-led method helps the Battery Pack Manufacturer configure the pack around the intended use.
A large medical cart, portable diagnostic unit and compact handheld device will not share the same energy or enclosure needs. MANLY Battery’s configurable voltage, capacity, dimensions, BMS current and physical interfaces allow each project to move from a device specification towards a purpose-built Custom Battery Pack.
Final Battery Pack Manufacturer Selection Framework
The final Battery Pack Manufacturer decision should use mandatory qualification gates before commercial scoring. Regulatory evidence, risk controls, configuration management and test traceability should not be traded against a lower price. Once the mandatory requirements are satisfied, the OEM can compare engineering responsiveness, production capacity, supply continuity and total programme cost across qualified suppliers.
Regulatory and Quality Gate
Confirm the intended markets, device classification and applicable conformity route. Review the supplier’s quality-system scope, battery safety reports, UN 38.3 documentation, traceability method and change-control process. Any evidence must correspond to the actual Custom Battery Pack, production site and component configuration.
The OEM should also define which records enter the medical-device technical documentation. A battery manufacturer may provide pack drawings, component specifications, risk-control evidence and production tests, while the legal manufacturer integrates these items into the complete device file and market submission.
Engineering and Validation Gate
Review how the Battery Pack Manufacturer converts device requirements into a battery specification. The assessment should cover cell selection, BMS architecture, charger compatibility, mechanical design, thermal limits, communications and end-of-life runtime. Require a staged sample plan with clear revision control and acceptance criteria.
A capable Battery Pack Manufacturer should explain each major design decision and link it to measurable evidence. The strongest candidate will also support device-level fault testing, root-cause analysis and controlled updates without losing the validated configuration.
Commercial and Supply Gate
Compare suppliers using total programme cost, not only production price. Include engineering charges, tooling, samples, testing support, packaging, logistics, warranty handling and potential revalidation costs. Review the battery manufacturer’s lead times, capacity, cell sourcing, obsolescence notice and response times for technical issues.
| Selection area | Mandatory evidence | Decision method |
|---|---|---|
| Regulatory alignment | Applicable market route and controlled supporting records | Pass or fail |
| Quality management | Certificate scope, traceability and change control | Pass or fail |
| Battery engineering | Requirements, design rationale and interface definition | Weighted score |
| Verification support | Relevant pack reports and device-level test support | Pass or fail |
| Manufacturing readiness | Pilot data, production controls and capacity | Weighted score |
| Supply continuity | Cell provenance, lifecycle monitoring and notice process | Weighted score |
| Commercial terms | Transparent development and production costs | Weighted score |
The right Battery Pack Manufacturer gives the medical OEM a controlled route from device requirements to repeatable production. By combining regulatory clarity, engineering evidence, risk-based testing and lifecycle support, the sourcing team can select a battery manufacturer that strengthens both product performance and long-term market readiness.
